Study of Regulatory T-Cells in Patients with Gastric Malt Lymphoma: Influence on Treatment Response and Outcome

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  García, Mar ^a   Bellosillo, Beatriz ^a   Sánchez González, Blanca ^a   García Payarols, Francesc ^a   Seoane, Agustin ^a   Ferrer, Ana Maria ^a   Gimeno, Eva ^a   Barranco, Luis Eugenio ^a   Torner, Ariadna ^a   Solé, Francesc ^a   Besses, Carles ^a   Serrano, Sergi ^a   Salar, Antonio ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BENDAMUSTINE; CD20 ANTIGEN; CD3 ANTIGEN; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; INTERFERON; OMEPRAZOLE; PREDNISONE; RIBAVIRIN; RITUXIMAB; TRANSCRIPTION FACTOR FOXP3; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CELL; CD3+ T LYMPHOCYTE; CELL COUNT; CELL KINETICS; CELLULAR DISTRIBUTION; CHRONIC GASTRITIS; CLINICAL ARTICLE; ERADICATION THERAPY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOCYTIC INFILTRATION; MALE; MARGINAL ZONE LYMPHOMA; REGULATORY T LYMPHOCYTE; STOMACH LYMPHOMA; STOMACH MARGINAL ZONE LYMPHOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; FORKHEAD TRANSCRIPTION FACTORS; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

BACTERIA (MICROORGANISMS);

EID: 84871271170     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051681     Document Type: Article

References (31)

1. Cavalli F, Isaacson PG, Gascoyne RD, Zucca E, (2001) MALT lymphomas. Hematology Am Soc Hematol Educ Program; pp. 241-58.
2. Hori S, Nomura T, Sakaguchi S, (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-61.
3. Sakaguchi S, Yamaguchi T, Nomura T, Ono M, (2008) Regulatory T cells and immune tolerance. Cell 133: 775-87.
4. Jiang H, Chess L, (2006) Regulation of immune responses by T cells. The new England journal of medicine 354: 1166-76.
5. Beyer M, Schultze JL, (2006) Regulatory T cells in cancer. Blood 108: 804-11.
6. Yang ZZ, Novak A, Ziesmer SC, Witzig TE, Ansell SM, (2007) CD70+ non-Hodgkin lymphoma B cells induce FOXP3 expression and regulatory function in intratumoral CD4+CD25- T cells. Blood 110: 2537-44.
7. Mittal S, Marshall NA, Duncan L, Culligan DJ, Barker RN, et al. (2008) Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma. Blood 111: 5359-70.
8. Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, et al. (2007) CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci U S A 104: 19446-51.
9. Farinha P, Al-Tourah A, Gill K, Klasa R, Connors JM, et al. (2010) The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation. Blood 115: 289-95.
10. Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, et al. (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351: 2159-69.
11. Glas AM, Knoops L, Delahaye L, Kersten MJ, Kibbelaar RE, et al. (2007) Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol 25: 390-8.
12. Lee AM, Clear AJ, Calaminici M, Davies AJ, Jordan S, et al. (2006) Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J Clin Oncol 24: 5052-9.
13. Alvaro T, Lejeune M, Salvadó MT, Lopez C, Jaén J, et al. (2006) Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol 24: 5350-7.
14. Carreras J, Lopez-Guillermo A, Fox BC, Colomo L, Martinez A, et al. (2006) High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 108: 2957-64.
15. Tzankov A, Meier C, Hirschmann P, Went P, Pileri SA, et al. (2008) Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 93: 193-200.
16. Kim WY, Jeon YK, Kim TM, Kim JE, Kim YA, et al. (2009) Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma. Annals of Oncology 20: 1688-96.
17. Alvaro T, Lejeune M, Salvado MT, Bosch R, García JF, et al. (2005) Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 11: 1467-73.
18. Gjerdrum LM, Woetmann A, Odum N, Hother C, Henrik-Nielsen R, et al. (2007) FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Leukemia 21: 2512-18.
19. De Jong D, Koster Ad, Hagenbeek A, Raemaekers J, Veldhuizen D, et al. (2009) Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols. Haematologica 94: 70-7.
20. Craig VJ, Cogliatti SB, Arnold I, Gerke C, Balandat JE, et al. (2010) B-cell receptor signiling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis. Leukemia 24: 1186-96.
21. Isaacson PG, Chott A, Nakamura S, Müller-Hemerlink HK, Harris NL,et al. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al., eds. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues.IARC Press: Lyon. 2008:214-17.
22. Rohatiner A, d'Amore F, Coiffier B, Crowther D, Gospodarowicz M, et al. (1994) Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 5: 397-400.
23. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, et al. (1999) Report of an internacional workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI sponsored International Working Group. J Clin Oncol 17: 1244-53.
24. Copie-Bergman C, Gaulard P, Lavergne-Slove A, Brousse N, Fléjou JF, et al. (2003) Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut 52: 1656.
25. Salar A, Bellosillo B, Serrano S, Besses C, (2005) Persistent residual disease in t(11;18)(q21;q21) positive gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy or rituximab. J Clin Oncol 23: 7361-2.
26. Lenz G, Wright G, Dave SS, Xiao W, Powell J, et al. (2008) Stromal gene signatures in large-B-cell lymphomas. N. Engl. J Med 359: 2313-23.
27. Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, et al. (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N. Engl. J Med 351: 2159-69.
28. Salar A, Domingo-Domenech E, Estany C, Canales MA, Gallardo F, et al. (2009) Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. Cancer 115: 5210-7.
29. Santón A, García-Cosio M, Bellosillo B, Rodríguez P, Cristóbal E, et al. (2008) Persistent monoclonality after histological remission in gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy and/or surgery: influence of t(11;18)(q21;q21). Leuk Lymphoma 49: 1516-22.
30. de Boer JP, Raderer M, van Tinteren H, Aleman BM, Boot H, et al. (2011) Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment. Leuk Lymphoma 52 (12):: 2262-9.
31. Ruskone-Fourmestraux A, Fischbach W, Aleman BMP, Boot H, et al. (2011) EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 60: 747-58.